Peter M. Chumakov

8.2k citations
175 papers · 6.7k indexed · 3 hit papers · h-index 38

Impact in

  • Oncology top 0.5%
    • Cancer-related Molecular Pathways
  • Biotechnology top 0.5%
    • Cancer Research and Treatments

Papers in

    • Cancer Research and Treatments 35
    • Cancer-related Molecular Pathways 57
    • CAR-T cell therapy research 14

Peter M. Chumakov

169 papers receiving 6.5k citations

Hit Papers

The antioxidant function of the p53 tumor suppressor 2005 · 905 citations
9052002202620102018250500750

Peers

Peter M. Chumakov
Comparison fields: 5 of 135
  • Oncology 3.0k
  • Biotechnology 822
  • Cancer Research 1.3k
  • Molecular Biology 4.6k
  • Aging 97
Replace Xinbin Chen with:
Xinbin Chen United States
Ted R. Hupp United Kingdom
Kristoffer Valerie United States
Roberto Mantovani Italy
Steven B. McMahon United States
David Pei‐Cheng Lin Taiwan
Sam W. Lee United States
Samuel Benchimol Canada
France Carrier United States
Vjekoslav Dulić France
Peter M. Chumakov relative to Xinbin Chen United States Xinbin Chen's profile →
Citations per field
00.5×1.6×
Xinbin Chen · 1×
Citations per year

Countries citing papers authored by Peter M. Chumakov

Since Specialization
Citations

This map shows the geographic impact of Peter M. Chumakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Chumakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Chumakov more than expected).

Fields of papers citing papers by Peter M. Chumakov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Chumakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Chumakov. The network helps show where Peter M. Chumakov may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter M. Chumakov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter M. Chumakov Line = papers co-authored together Peter M. Chumakov links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20243
4 202311
5 20232
6 202210
7 20229
8 20202
9 20183
10 201834
11 201715
12 201713
13 201554
14 201210
15 2010122
16 201016
17 2008160
18 2007116
19 199939
20 19897

About Peter M. Chumakov

Peter M. Chumakov is a scholar working on Biotechnology, Oncology, Genetics, Molecular Biology and Aging, having authored 175 papers that have together received 6.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (72 papers), Cancer-related Molecular Pathways (57 papers), Cancer Research and Treatments (35 papers), Viral Infectious Diseases and Gene Expression in Insects (15 papers), RNA Interference and Gene Delivery (14 papers), Viral gastroenteritis research and epidemiology (14 papers), CAR-T cell therapy research (14 papers) and RNA modifications and cancer (14 papers). The work is most often cited by research in Oncology (3.0k citations), Biotechnology (822 citations), Cancer Research (1.3k citations), Molecular Biology (4.6k citations) and Aging (97 citations). Peter M. Chumakov has collaborated with scholars based in Russia, United States and United Kingdom. Frequent co-authors include Anna Sablina, Andrei V. Budanov, J. E. Kravchenko, Larissa S. Agapova, G. V. Ilyinskaya, Kopnin Bp, Elena Feinstein, Eugene V. Koonin, Elena N. Pugacheva and Andrei V. Gudkov. Their work appears in journals such as Oncogene, Cancers, Nucleic Acids Research, Oncotarget and Molecular Therapy — Oncolytics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026